Archive
68 stories
Yale scientists found a hidden retinal network that regulates light adaptation, affecting over 2.2 billion people with vision issues worldwide (WHO, 2024). Learn its impact on eye health.
In 2023, only 2.8% of US inpatient deaths were declared via neurologic criteria, showing how complex death determination really is.
GLP-1 receptor agonists treat diabetes, obesity, and cardiovascular risk. We break down how semaglutide and tirzepatide work, who benefits, what they cost, and what the 2026 evidence shows about muscle loss.
Fast weight loss on GLP-1 drugs can cost you muscle. Here is what 2026 research says about preserving strength while the scale drops.
Two 2026 studies link perimenopause to doubled cardiovascular risk, yet referrals to advanced heart care remain rare. Here is what women need to ask.
Hormonal shifts, not willpower, drive midlife weight changes. An endocrinologist explains what actually works.
Longevity science spent decades on male data. In 2026 the focus finally turns to women's biology, ovarian aging, and healthspan.
Ultra-processed foods are linked to higher death and cognitive risk. We cut through the hype with the 2025-2026 evidence.
Protein is the 2026 nutrition obsession for good reason. Here is the evidence-based amount you need, and where to get it.
